Hasil Pencarian - Zobair M. Younossi

Perbaiki Hasil
  1. 1
    Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

    Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis oleh Aybike Birerdinc, Zobair M. Younossi

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Review: Treatment options for nonalcoholic fatty liver disease

    Review: Treatment options for nonalcoholic fatty liver disease oleh Brian Lam, Zobair M. Younossi

    Diterbitkan 2010-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinomaKey points

    Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinomaKey points oleh Zobair M. Younossi, Linda Henry

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Treatment regimens for non-alcoholic fatty liver disease

    Treatment regimens for non-alcoholic fatty liver disease oleh Brian P. Lam, Zobair M. Younossi

    Diterbitkan 2009-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Pediatric Non-Alcoholic Fatty Liver Disease

    Pediatric Non-Alcoholic Fatty Liver Disease oleh Haley Bush, Pegah Golabi, Zobair M. Younossi

    Diterbitkan 2017-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Nonalcoholic steatohepatitis: global impact and clinical consequences

    Nonalcoholic steatohepatitis: global impact and clinical consequences oleh Khaled Kabarra, Pegah Golabi, Zobair M Younossi

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC

    Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC oleh Zobair M. Younossi, Maria Stepanova, Issah Younossi, Andrei Racila

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis

    Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis oleh Mehmet Sayiner, Brian Lam, Pegah Golabi, Zobair M. Younossi

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

    The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment oleh Brian P. Lam, Thomas Jeffers, Zahra Younoszai, Yousef Fazel, Zobair M. Younossi

    Diterbitkan 2015-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality

    Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality oleh Omer Shahab, Rakesh Biswas, James Paik, Haley Bush, Pegah Golabi, Zobair M. Younossi

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

    Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States oleh Pegah Golabi, James Paik, Rashmi Reddy, Elisabetta Bugianesi, Gregory Trimble, Zobair M. Younossi

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease

    Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease oleh Pegah Golabi, Natsu Fukui, James Paik, Mehmet Sayiner, Alita Mishra, Zobair M. Younossi

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Predictors of chronic liver disease in individuals with human immunodeficiency virus infection

    Predictors of chronic liver disease in individuals with human immunodeficiency virus infection oleh Nila Rafiq, Maria Stepanova, Brian Lam, Fatema Nader, Manirath Srishord, Zobair M. Younossi

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection

    The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection oleh Pegah Golabi, Munkhzul Otgonsuren, Mehmet Sayiner, Aimal Arsalla, Trevor Gogoll, Zobair M. Younossi

    Diterbitkan 2017-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Association of Parity in Patients with Chronic Liver Disease

    Association of Parity in Patients with Chronic Liver Disease oleh Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Carey Escheik, Mehmet Sayiner, Zobair M. Younossi

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Statin use is not associated with liver related mortality

    Statin use is not associated with liver related mortality oleh Zahra Younoszai, Li Zheng, Maria Stepanova, Madeline Erario, Rebecca Cable, Zobair M. Younossi

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities

    Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities oleh Pegah Golabi, James M. Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M. Younossi

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States’ National Vital Statistics System

    Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States’ National Vital Statistics System oleh James M. Paik, Dipam Shah, Katherine Eberly, Pegah Golabi, Linda Henry, Zobair M. Younossi

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States

    Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States oleh James M. Paik, Pegah Golabi, Rakesh Biswas, Saleh Alqahtani, Chapy Venkatesan, Zobair M. Younossi

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life

    The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life oleh Manisha Verma, James M. Paik, Issah Younossi, Daisong Tan, Hala Abdelaal, Zobair M. Younossi

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: